Development of a Competitive Direct Enzyme-Linked Immunosorbent Assay for Teicoplanin

  • Published : 2004.06.01

Abstract

A competitive direct enzyme-linked immunosorbent assay (cdELISA) was developed for selective and rapid detection of a glycopeptide antibiotic, teicoplanin (TP). TP was conjugated to bovine serum albumin (BSA) for use as an immunogen. Repeated subcutaneous injections of 0.5 mg of the conjugate was effective in generating specific polyclonal antibody (PAb) toward TP in rabbits, as determined by cdELISA. TP-horseradish peroxidase conjugate (TP-HRP) was used as an enzyme marker. The cdELISA was developed based on a competition reaction between TP-BSA PAb and TP-HRP conjugate. The TP-BSA PAb was highly sensitive (detection limit, 0.3 ng/ml and specific toward teicoplanin, showing no cross-reactivity to other glycopeptide antibiotics including vancomycin. There were good correlations ($r^2$=0.84 and 0.76, respectively) between cdELISA and microbiological assay, and high-performance liquid chromatography. The cdELISA system developed in this work is expected to be useful not only for selective and rapid monitoring of TP but also for study of TP pharmacokinetics.

Keywords

References

  1. Clin. Microbiol. Infect. v.5 Pharmacokinetics of teicoplanin during plasma exchange Alet,P.;O.Lortholary;F.Fauvelle;M.Tod;T.Genereau;M.Louchahi;A.Leon;L.Guillevin;O.Petitjean https://doi.org/10.1111/j.1469-0691.1999.tb00126.x
  2. Antimicrob. Agents Chemother. v.35 Randomized study of vancomycin versus teicoplanin for the treatment of Gram positive bacterial infections in immunocompromised hosts Auwera,P.V.;M.Aoun;F.Meunier https://doi.org/10.1128/AAC.35.3.451
  3. Ther. Drug Monit. v.13 Teicoplanin measurement in patients with renal failure:Comparison of fluorescene in patiests with real failure:Comparison of fluorescence polarization immunoassay,microbiological assay,and high-performance liquid chromatographic assay Awni,W.M.;W.L.St Peter;D.R.Guay;M.T.Kenny;G.R.Matzke https://doi.org/10.1097/00007691-199111000-00008
  4. J. Antibiot. v.31 Teichomycins,new antibiotics from Actinoplanes teicomyceticus nov.sp. Bardone,M.R.;M.Paternoster;C.Coronelli https://doi.org/10.7164/antibiotics.31.170
  5. Annu. Rev. Microbiol. v.38 The structure and mode of action of glycopeptide antibiotics of the vancomycin group Barna,J.C.J.;D.H.William https://doi.org/10.1146/annurev.mi.38.100184.002011
  6. Methods Enzymol. v.70 The use of carbodimides in the preparation of immunizing conjugates Bauminger,S.;W.Wilchek https://doi.org/10.1016/S0076-6879(80)70046-0
  7. Antimicrob. Agents Chemother. v.36 Teicoplanin metabolism in humans Bernareggi,A.;A.Borghi;M.Borgonovi;L.Cavenaghi;P.Ferrari;K.Vekey;M.Zanol;L.F.Zerilli https://doi.org/10.1128/AAC.36.8.1744
  8. Antimicrob. Agents Chemother. v.31 Clinical evaluation of efficacy,pharmacokinetics,and safety of teicoplanin for serious Gram-positive infections Bibler,M.R.;T.F.Peter;D.N.Hagler;R.B.Bode;J.L.Staneck;V.Thamlikitkul https://doi.org/10.1128/AAC.31.2.207
  9. J. Antibiot. v.37 Teicomycins,new antibiotics from Actinoplanes teicomyceticus nov.sp.Ⅳ.Separation and characterization of the components of teicomycin(teicoplanin) Borghi,A.;C.Coronelli;L.Faniuolo;G.Allievi;R.Pallanza;G.G.Gallo https://doi.org/10.7164/antibiotics.37.615
  10. Drugs v.47 Teicoplanin.A reappraisal of its antimicrobial activity,pharmacokinetic properties and therapeutic efficacy Brogden,R.N.;D.H.Peters;R.N.Brogden;D.H.Peters https://doi.org/10.2165/00003495-199447050-00008
  11. J. Hosp. Infect. v.7 Comparison of the solid-phase enzyme-receptor assay(SPERA)and the microbiological assay for teicoplanin Cavenaghi,L.;A.Corti;G.Cassani https://doi.org/10.1016/0195-6701(86)90012-5
  12. Clin. Chem. v.33 A receptor-antibody sandwich assay for teicoplanin Corti,A.;L.Cavenaghi;E.Giani;G.Cassani
  13. Clin. Chem. v.31 Solid phase enzyme-receptor assay(SPERA):A competitive binding assay for antibiotics of the vancomycin class Corti,A.;C.Rurali;A.Borghi;G.Cassani
  14. J. Chromatogr. v.529 Interfacing microbore and capillary liquid chromatography to continuous-flow fast atom bombardment mass spectrometry for the analysis of glycopeptides Coutant,J.E.;T.M.Chen;B.L.Ackermann https://doi.org/10.1016/S0378-4347(00)83833-5
  15. Antimicrob. Agents Chemother. v.37 Evaluation of a novel fluorescence polarization immunoassay for teicoplanin Cox,H.;M.Whitby;G.Nimmo;G.Williams https://doi.org/10.1128/AAC.37.9.1924
  16. Comb. Chem. High Throughput Screen v.6 Fluorescence polarization immunoassay for pesticides Eremin,S.A.;D.S.Smith https://doi.org/10.2174/138620703106298301
  17. Antimicrob. Agents Chemother. v.31 Pharmacokinetics of teicoplanin in renal failure Falcoz,C.;N.Ferry;N.Pozet;G.Cuisinaud;P.Y.Zech;J.Sassard https://doi.org/10.1128/AAC.31.8.1255
  18. Antimocrob. Agents Chemother. v.34 Percentages and distribution of teicoplanin and vancomycin resistant strains among coagulase negative Staphylococci Goldstein,F.W.;A.Coutrot;A.Sieffer;J.F.Acor https://doi.org/10.1128/AAC.34.5.899
  19. J. Biol. Chem. v.275 Biosynthetic studies of the glycopeptide teicoplanin by ¹H and $^13C$NMR Heydorn,A.;B.O.Petersen;J.Ø.Duus;S.Bergmann;T.Suhr-Jessen;J.Nielsen https://doi.org/10.1074/jbc.275.9.6201
  20. Antimicrob. Agents Chemother. v.31 Determination of teicoplanin concentrations inserum by high-pressure liquid chromatography Joos,B.;R.Luthy https://doi.org/10.1128/AAC.31.8.1222
  21. J. Microbiol. Biotechnol. v.13 Detection of miotic centromere-associated kinesin(MCAK)during cell cycle progression of human jurkat T cells using polyclonal antibody raised against its N-terminla region overexpressed in E.coli Jun,D.Y.;S.W.Rue;B.W.Kim;Y.H.Kim
  22. Antimicorb. Agents Chemother. v.34 Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropensic patients Kureishi,A.;P.J.Jewesson;K.H.Bartlett;C.D.Cole;A.W.Chow https://doi.org/10.1128/AAC.34.9.1642
  23. Nature v.227 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Laemmli,U.K. https://doi.org/10.1038/227680a0
  24. Lett. Appl. Microbiol. v.37 Improved production of teicoplanin using adsorbent resin in fermentations Lee,J.C.;H.R.Park;D.J.park;H.B.Lee;Y.B.Kim;C.J.Kim https://doi.org/10.1046/j.1472-765X.2003.01409.x
  25. Diagn. Microbiol. Infect. Dis. v.16 Performance of a fluorescence polarization immunoassay for teicoplanin in serum Mastin,S.H.;R.L.Buck;P.A.Mueggler https://doi.org/10.1016/0732-8893(93)90125-Q
  26. J, Antimicrob. Chemother. v.50 Assay of teicoplanin in serum:Comparison of high-performnace liquid chromatography and fluorescence polarization immunoassay McCann,S.J.;L.O.White;B.Keevil https://doi.org/10.1093/jac/dkf067
  27. J. Antimicrob. Chemother. v.34 Assay of serum teicoplanin concentrations in clinical specimens:A comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay McMullin,C.M.;L.O.White;A.P.MacGowan;H.A.Holt;A.M.Lovering;D.S.Reeves https://doi.org/10.1093/jac/34.3.425
  28. Diagn. Microbiol. Infect. Dis. v.16 Performance of a fluorescence polarization immunoassay for teicoplanin in serum Mastin,S.H.;R.L.Buck;P.A.Mueggler https://doi.org/10.1016/0732-8893(93)90125-Q
  29. J. Antimicrob. Chemother. v.9 The basis of immunoassay for antibiotics Munro,A.J.;J.Landon;E.J.Shaw https://doi.org/10.1093/jac/9.6.423
  30. J. Antibiot. v.31 Teichomycins,new antibiotics from Actinoplanes teichomyceticus nov.sp.Ⅰ.Description of the producer strain,fermentation studies and biological properties Parenti,F.;G.Beretta;M.Berti;V.Arioli https://doi.org/10.7164/antibiotics.31.276
  31. J. Antimicrob. Chemother. v.51 Teicoplanin therapeutic drug monitoring in critically ill patients:A retropective study emphasizing the importance of a loading dose Pea,F.;L.Brollo;P.Viale;F.Pavan;M.Furlanut https://doi.org/10.1093/jac/dkg147
  32. Eur. J. Clin. Microbiol. Infect. Dis. v.8 Structure,biochemistry and mechanism of action of glycopeptide antibiotics Reynolds,P.E. https://doi.org/10.1007/BF01967563
  33. J. Chromatogr. v.421 Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high performance liquid chromatography Riva,E.;N.Ferry;A.Cometti;G.Cuisinaud;G.G.Gallo;J.Sassard https://doi.org/10.1016/0378-4347(87)80383-3
  34. Antimicrob. Agents Chemother v.26 Teicoplanin,a new antibioatic from Actinoplanes teicomyceticus sp.nov.:Mechanism of action. Somma,S.;L.Gastaddo;A.Corti https://doi.org/10.1128/AAC.26.6.917
  35. J. Chromatogr. v.563 Determination of teicoplanin in plasma using microbore high-performance liquid chromatography and injection generated gradients Taylor,R.B.;R.G.Reid;I.M.Gould https://doi.org/10.1016/0378-4347(91)80055-H
  36. J. Hosp. Infect. v.7 Teicoplanin in the treatment of infections caused by Gram-positive organisms Williams,A.H.;R.N.Gruneberg;A.Webster;G.I.Ridgway https://doi.org/10.1016/0195-6701(86)90014-9
  37. Clin. Pharmacokinet. v.39 Clinical pharmacokinetics of teicoplanin Wilson,A.P. https://doi.org/10.2165/00003088-200039030-00001